JPWO2023076615A5 - - Google Patents
Info
- Publication number
- JPWO2023076615A5 JPWO2023076615A5 JP2024525528A JP2024525528A JPWO2023076615A5 JP WO2023076615 A5 JPWO2023076615 A5 JP WO2023076615A5 JP 2024525528 A JP2024525528 A JP 2024525528A JP 2024525528 A JP2024525528 A JP 2024525528A JP WO2023076615 A5 JPWO2023076615 A5 JP WO2023076615A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical composition
- administration period
- alkyl
- during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273540P | 2021-10-29 | 2021-10-29 | |
| US63/273,540 | 2021-10-29 | ||
| PCT/US2022/048249 WO2023076615A1 (en) | 2021-10-29 | 2022-10-28 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating chronic rhinosinusitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540142A JP2024540142A (ja) | 2024-10-31 |
| JP2024540142A5 JP2024540142A5 (https=) | 2025-11-06 |
| JPWO2023076615A5 true JPWO2023076615A5 (https=) | 2025-11-06 |
Family
ID=86158626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525528A Pending JP2024540142A (ja) | 2021-10-29 | 2022-10-28 | 慢性副鼻腔炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049813A1 (https=) |
| EP (1) | EP4423071A4 (https=) |
| JP (1) | JP2024540142A (https=) |
| KR (1) | KR20240099179A (https=) |
| CN (1) | CN118159525A (https=) |
| AU (1) | AU2022376535A1 (https=) |
| CA (1) | CA3236069A1 (https=) |
| MX (1) | MX2024005126A (https=) |
| WO (1) | WO2023076615A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) | 2014-01-24 | 2018-02-24 | ||
| KR20250002710A (ko) | 2018-03-01 | 2025-01-07 | 아스트라제네카 에이비이 | (2s)-n-｛(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸｝-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물 |
| AU2019306532A1 (en) | 2018-07-17 | 2021-03-04 | Insmed Incorporated | Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis |
| EP4646265A1 (en) | 2023-01-06 | 2025-11-12 | Insmed Incorporated | Novel, reversible dpp1 inhibitors and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) * | 2014-01-24 | 2018-02-24 | ||
| KR20250002710A (ko) * | 2018-03-01 | 2025-01-07 | 아스트라제네카 에이비이 | (2s)-n-｛(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸｝-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물 |
| WO2020023962A1 (en) * | 2018-07-27 | 2020-01-30 | Massachusetts Eye And Ear Infirmary | Inhibition of cystatins for the treatment of chronic rhinosinusitis |
-
2022
- 2022-10-28 US US18/704,872 patent/US20250049813A1/en active Pending
- 2022-10-28 CA CA3236069A patent/CA3236069A1/en active Pending
- 2022-10-28 AU AU2022376535A patent/AU2022376535A1/en active Pending
- 2022-10-28 EP EP22888256.9A patent/EP4423071A4/en active Pending
- 2022-10-28 MX MX2024005126A patent/MX2024005126A/es unknown
- 2022-10-28 KR KR1020247012416A patent/KR20240099179A/ko active Pending
- 2022-10-28 WO PCT/US2022/048249 patent/WO2023076615A1/en not_active Ceased
- 2022-10-28 JP JP2024525528A patent/JP2024540142A/ja active Pending
- 2022-10-28 CN CN202280071367.5A patent/CN118159525A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6931019B2 (ja) | 多発性硬化症を処置するためのｓ１ｐ受容体モジュレーター | |
| ES2617628T3 (es) | Régimen de dosificación para un agonista selectivo del receptor de S1P1 | |
| JP2015526458A5 (https=) | ||
| KR20110042280A (ko) | 저용량 토피라메이트/펜테르민 조성물 및 그의 사용 방법 | |
| CN101291663A (zh) | 预防和治疗睡眠呼吸障碍的方法和工具 | |
| JP2025515491A5 (https=) | ||
| JP4896334B2 (ja) | 睡眠時呼吸障害を治療及び診断する方法並びにその方法を実施する手段 | |
| Stentz et al. | Effect of a combination of intranasal ketorolac and nitrous oxide on the success of the inferior alveolar nerve block in patients with symptomatic irreversible pulpitis: a prospective, randomized, double-blind study | |
| JPWO2023076615A5 (https=) | ||
| JPWO2020146362A5 (https=) | ||
| WO2005049043A1 (en) | Combination therapy comprising metformin and anticonvulsant agents | |
| JP2022177119A5 (https=) | ||
| Shin et al. | Dental treatment in patients with severe gag reflex using propofol-remifentanil intravenous sedation | |
| JPWO2020018551A5 (https=) | ||
| JPWO2023159120A5 (https=) | ||
| WO1997024126A1 (en) | Malignant tumor metastasis inhibitors | |
| JPWO2020234781A5 (https=) | ||
| JP7442023B1 (ja) | 歯科用の局所麻酔用注射液 | |
| JPWO2022094133A5 (https=) | ||
| JPWO2020023324A5 (https=) | ||
| JP2013511528A (ja) | 喘息の急性憎悪の治療及びそれに罹患した患者の入院の可能性の低減 | |
| JPWO2023100070A5 (https=) | ||
| JPWO2022101227A5 (https=) | ||
| Ma et al. | Research Progress of Esketamine in Painless Endoscopy | |
| JP2002068985A (ja) | 薬剤性肝障害治療薬 |